[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336263-105":59,"doc-detail-336263-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","correspondence-a-commentary-on-organ-preservation-strategies-after-neoadjuvant-chemoimmunotherapy-in-resectable-non-small-cell-lung-cancer-a-multicenter-retrospective-cohort-study","Correspondence - A commentary on ‘Organ preservation strategies after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a multicenter retrospective cohort study’","","A correspondence provides commentary on a multicenter retrospective cohort study evaluating organ preservation strategies for central-type non-small cell lung cancer after neoadjuvant chemoimmunotherapy. The authors discuss feasibility for selected patients with positive safety and long-term survival, while highlighting limitations including bias from clinical features, absence of key variables such as BMI, tumor location, and sickness history. They emphasize the need for careful postoperative management, further prospective multicenter studies, broader population validation, and deeper analyses of indications and risk factors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/correspondence-a-commentary-on-organ-preservation-strategies-after-neoadjuvant-chemoimmunotherapy-in-resectable-non-small-cell-lung-cancer-a-multicenter-retrospective-cohort-study/336263/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/correspondence-a-commentary-on-organ-preservation-strategies-after-neoadjuvant-chemoimmunotherapy-in-resectable-non-small-cell-lung-cancer-a-multicenter-retrospective-cohort-study/336263.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this correspondence?","Question",{"text":112,"@type":113},"It comments on organ preservation strategies after neoadjuvant chemoimmunotherapy for resectable central-type non-small cell lung cancer, reviewing findings and limitations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which patient factors may introduce bias in the discussed study?",{"text":117,"@type":113},"The commentary notes bias related to clinical features of NSCLC patients, including the lack of data such as BMI, tumor location, and sickness history.",{"name":119,"@type":110,"acceptedAnswer":120},"What follow-up research does the correspondence call for?",{"text":121,"@type":113},"It recommends more thorough, prospective, multicenter studies to confirm observations, validate results in broader populations, and refine indications and risk-factor analyses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336263,1792241400,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":14,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":24,"preview_page_count":14,"preview_urls":144},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","’Correspondence  \nA commentary on ‘Organ preservation strategies after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a multicenter retrospective cohort study’  \nYuanyuan Wang, BSca , Limei Zhan, BScb , Yongchao He, BScc , Xiaoyu Liu, BScd , Shasha Sun, BSca,*  \nIt is with great interest that we read the article published in the International Journal of Surgery. Hui et al. [1] performed amulticenter retrospective cohort study on patients with central-type non-small cell lung cancer (NSCLC) who received 2–4 cycles of neoadjuvant chemoimmunotherapy. The study’s ﬁndings demonstrated that for a subset of patients with central-type NSCLC who have positive safety and longterm survival, it is possible to apply organ preservation methods, such as modifying surgery following neoadjuvant chemoimmunotherapy.  \nNSCLC accounts for 85% of newly diagnosed instances of lung cancer, which continues to be the primary cause of cancerrelated deaths globally[2] . Multidisciplinary therapy approaches, such as surgery combined with related systemic therapies, have grown popular in an effort to improve prognosis[3] . This study examines the long-term survival and safety of organ preservation techniques in patients with central-type NSCLC who underwent radical excision after neoadjuvant chemotherapy. This creative approach provides enlightening guidance and inspiration for the continued development of this area of research. However, there were numerous limits.  \nBias resulted from the clinical features of NSCLC patients, not including BMI, tumor location, or sickness history. Published literature has demonstrated that postoperative complication risk was found to be signiﬁcantly associated with a low BMI[4] . The possible reasons for this might be poor respiratory compliance, decreased lung volume, and longer operation time for overweight patients. Based on this experience, the most important factor in preventing these patients from developing postoperative  \naPulmonary and Critical Care Medicine, bDisinfection Supply Center, cOperating Room, Yantai Yuhuangding Hospital, Yantai and dDepartment of Emergency, Jinan  \nChildren ’s Hospital, Jinan, Shandong, People ’s Republic of China Yuanyuan Wang and Limei Zhan contributed equally to this article.  \nSponsorships or competing interests that maybe relevant to content are disclosed atthe end of this article.  \n*Corresponding author. Address: Pulmonary and Critical Care Medicine, Yantai Yuhuangding Hospital, No.20Yudong Road, Zhifu District, Yantai City, Shandong Province 264000, China. Tel.: +[86 0535 669 6999. E-mail: huhey123456@163.com](86 0535 669 6999. E-mail: huhey123456@163.com) (S. Sun).  \nCopyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms.  \nInternational Journal of Surgery (2024) 110:3132–3133  \nReceived 14 January 2024; Accepted 13 February 2024  \nPublished online 4 March 2024  \n[http://dx.doi.org/10.1097/JS9.0000000000001229](http://dx.doi.org/10.1097/JS9.0000000000001229)  \ncomplications is thorough and appropriate postoperative care starting on the day of surgery, including increased physical therapy, respiratory therapy, and aggressive prophylactic anticoagulant drug therapy. Additionally, published research has shown that whereas patients with tumors on the right who have surgery are linked to higher postoperative complications and mortality, patients with tumors on the left are connected with a protective effect against postoperative issues[5] . The right lung’s architectural features were the primary cause of the lung’s increased difﬁculty during surgery, increased alveolar volume loss, and decreased respiratory function. In general, patients with a tumor","cbCaicJOoCRCkSeo","https://ap.wps.com/l/cbCaicJOoCRCkSeo","pdf",200309,"English","# Correspondence overview\n## Summary of the multicenter retrospective findings\n## Limitations and potential sources of bias\n## Clinical implications and need for further studies","[{\"question\":\"What is the main focus of this correspondence?\",\"answer\":\"It comments on organ preservation strategies after neoadjuvant chemoimmunotherapy for resectable central-type non-small cell lung cancer, reviewing findings and limitations.\"},{\"question\":\"Which patient factors may introduce bias in the discussed study?\",\"answer\":\"The commentary notes bias related to clinical features of NSCLC patients, including the lack of data such as BMI, tumor location, and sickness history.\"},{\"question\":\"What follow-up research does the correspondence call for?\",\"answer\":\"It recommends more thorough, prospective, multicenter studies to confirm observations, validate results in broader populations, and refine indications and risk-factor analyses.\"}]","Correspondence - A commentary on ‘Organ preservation strategies after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a multicenter retrospective cohort study’ | PDF",1790014294,[145,149],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5589b0e37c13e0a8895528951033f55.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/950b2d1a0598936a4b5e7250e0a8943b.webp",982,1309]